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Background: The aim of this study is to evaluate in-house antibiotic use in a state hospital in Turkey with its cost,
using the ATC/DDD index, which is an accepted standard method.
Methods: This study was performed as a point prevalence study in a state hospital with 372 beds. All in-house
patients using antibiotics on July 19, 2011 were included in the study. Indications for antibiotic use and information
about the patients were recorded on special forms. Antibiotic use and cost analysis were evaluated using the ATC/
DDD index, which is also suggested by the WHO to be used in similar studies.
Findings: 147 patients out of 308 patients who were in-house were identified to use antibiotics with appropriate
indications for prophylaxis or treatment in 61% of the patients. The rate of appropriate antibiotic use was identified
to be in 78%, while this rate was 38.9% in surgical clinics. The daily cost of the antibiotics consumed on the date of
the study was calculated as 4104.79 TL (=2476.80 USD).
Discussion: The rate of inappropriate use of antibiotics seems to be high in our hospital. This will result in both
increased costs and also increased nosocomial infection rates with resistant species. Infectious disease specialists
should take more active roles in the in-house antibiotic use, hospitals should prepare and implement their own
principles of antibiotic use, and microbiology laboratories should be used more effectively. These measures would
decrease the conspicuous shortcomings in the antibiotic use.
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As the anti infective agents are most frequently used
group of drugs in our country, also doctors most fre-
quently error when chosing them [1,2]. Improper use
of antibiotics often lead to many problems such as;
development of resistance to antibiotics, negative effects
on the ecological balance, side effects on patients, trig-
gering of superinfections and increase in treatment
costs [3-5]. The most important feature that separates
antibiotics from other drugs is that their improper use
does not only negatively affect patients but also has
negative impact on the hospital microbial environment.
As a result, while infections caused by resistant micro-
organisms gradually increase, antimicrobial options
used for treating them rapidly diminish [6,7]. In this
case, the accurate determination of antibiotic therapy* Correspondence: dribak77@hotmail.com
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reproduction in any medium, provided the orwill prevent the use of incorrect and inappropriate anti-
biotics [8].
Unnecessary use of antibiotics is a major worldwide
problem. Despite of detailed research on trends of anti-
biotic use in and out of the hospitals in many countries,
no sufficient data is available for our country [9].
Because each antibiotic has different unit dose of daily
administration, a specific standardized method should
be used in the evaluation of in-hospital antibiotic use.
Of the current standard methods, the method suggested
by the World Health Organization (WHO) is the promin-
ent. The ATC/DDD index is developed and intervaly
updated by the WHO. The WHO Collaborating Centre
for Drugs Statistics Methodology has standardized this
with the ATC/DDD (Anatomical Therapeutic Chemical/
Defined Daily Dose) index [10]. DDD 100 bed-days has
been used internationally in the comparison of in-hospital
and outpatient antibiotic use, and such data have been
used to compare and to throw light on the national leveltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing antibiotic use intensity with the ATC/DDD index is
independent from the price and box dimensions, and
the daily dose for every antibiotic expresses the same
DDD. By using this method, a comparison of antibiotic
use can be made not only in clinics and hospitals but at
the same time among countries. However, because it is
based on adults only, low or high dose applications due
to chronic renal and liver failure can change the sum.
Generally, the ATC/DDD index is a universal parameter
used in the evaluation of antibiotic use [12-17].
The aim of this study was to evaluate the use and cost
of antibiotics in a Turkish state hospital by a point
prevalence research with the ATC/DDD index which is
accepted as a standard.Methods
Isparta State Hospital is a secondary healthcare facility
with 372 bed capacity and 4 different intensive care
units with 21 bed capacity.
A research of modified point prevalence research was
carried out in order to evaluate the frequency and ap-
propriate use of antibiotics in our hospital. The data of
this study were obtained from 7 departments of internal
diseases (internal medicine, neurology, chest diseases,
cardiology, dermatology, physical therapy and rehabilita-
tion(PRT), infectious diseases), 8 departments of surgical
diseases (neurosurgery, Ear, Nose, and Throat/Head and
Neck Surgery(ENT), cardiovasculer surgery(CVS), thoracic
surgery, general surgery, orthopedics, urology and plastic
surgery) and 4 intensive care units (anesthesia, internal
medicine, neurology, chest diseases). Data concerning
antibiotic use in the hospital were collected on the 19th
of July 2011 by an infectious diseases specialist and all
patients receiving antibiotics were included to the study.
Data were collected from patient charts using a standard
form; patients personal information, underlying disease,
the name of the antibiotic in use, dosage, usage, duration,
reason of antibiotic use (prophylaxis, empyrical, micro-
biologically prooven infection) and microbiological test
results were recorded on the form.
Th existence of an infectious disease was detected by
evaluating patient’s clinical complaints, physical examin-
ation findings and laboratory findings all together. In
diagnosing nosocomial infections, CDC (The Centers for
Disease Control) criteria and NNIS (National Nosoco-
mial Infections Surveillance System) methodology were
used [18]. The antimicrobial suitability was evaluated
according to the criteria described by Kunin and Jones
and The Sanford Guide to Antimicrobial Therapy [19-21].
Surgical prophylaxis was evaluated taking into account
the drug dose, administration way, duration of prophy-
laxis and international guidelines [22].Patients using antibiotics were evaluated according to
suitable indication, dose, administration way and criteria
for adequate antibiotic. When evaluated by the infectious
diseases specialist, patients matching all criteria were
accepted as “suitable”, and in the absence of even one
criteria the patient was “non-suitable”.
The DDD is the assumed average maintenance dose
per day for a drug used for its main indication in adults.
Only drugs with an ATC code can have DDD values.
The DDD value in grams of every drug is defined by the
WHO and is periodically updated. DDD values of every
antibiotic is calculated separately [10].
Defined Daily Doses (DDDs) are calculated separately
for every antibiotic, the average maintenance dose for an
adult weighing 70 kg is prepared in main indications and
the active substance should be taken as grams (or I.U.).
DDDs = Number of boxes x number of tablets in the
box or number of vials x tablets in grams or the weigh
of the vial / the DDD value of the antibiotic in grams.
In this calculation method, the form used for in-bed
patients is the ratio of the total DDD per 100-bed-days.
This index is called antimicrobial consumption index
(ACI).
ACI ¼ DDD=bed−days 100
Also, the antibiotic consumption index of a country or
geographical area at a certain period of time is calculated
by DDD per 1000 people.
The number obtained is the antibiotic consumption
index of that hospital/clinic or population.
In this study, DDDs of anti infective agents are listed
for systemic use according to ATC/DDD 2010 Index.
The total cost of every antibiotic used in the hospital
was calculated according to the price list of the General
Directorate of Pharmaceuticals of The Republic of Turkey
on the 19th of July 2011. Afterwards, the cost was
converted to USD according to the exchange rates of
the Central Bank of The Republic of Turkey on the
19th of July 2011 (1 USD = 1,6573 TL).
Results
The mean age of the 308 patients was 56.7 + 18.2. Of the
patients included to the study, 161 were male (52.3%),
and 147 were female (47.7%). Of the 308 patients, 147
(47%) received antibiotics for any reason. Of the 147
patients, 47 (32%) received antibiotics for surgical anti-
microbial prophylaxis, 92 (62.6%) empirical antimicrobial
therapy and only 8 patients (5.4%) received antibiotics
based on microbiological data.
When evaluating the 147 patients using antibiotics,
61.9% were evaluated as “appropriate” and the rate in
the clinics of internal diseases was 76.6%, in the surgical
clinics 38.9%, in the intensive care units 81.8%. According
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antibiotics 5 are intensive care patients, and while 45.5%
of the patients from the intensive care units receive antibi-
otics according to microbiological data, in the depart-
ments of internal and surgical diseases this is only 2.6%
and 1.7% respectively (Table 1).
The rate of antibiotic use in the departments for in-
ternal diseases was 42.5%, in the surgical departments
52.2% and in the intensive care units 78.6% (Table 1).
While the highest rate of antibiotic use in the depart-
ments for internal diseases was in the department for
pulmonary disease 89.8%, in infectious diseases 75% and
in dermatology 66.7%, the lowest rate was found to be in
the department for internal medicine with 7.1% and the
neurology clinic with 4.8%. In the surgical departments;
chest surgery (70%), plastic surgery (66.7%), brain sur-
gery and CVS (60%) had the highest rates of antibiotic
use while, urology and ENT (33.3%) had the lowest rates
of antibiotic use (Table 2).
The mean duration of surgical prophylaxis was 4.74 days
(minimum 1, maximum 17 days). Duration of surgical
prophylaxis according to the clinics was; orthopedics
9.5, thoracic surgery 6.8, general surgery 2.1, urology
1.4, ENT 1.3 days, respectively. The only service where
third generation cephalosporins were used in surgical
prophylaxis was thoracic surgery.
In our study, cephalosporins were found to be the most
frequently used antimicrobials among all antibiotics,
with a rate of 57%. Among the cephalosporins, 3rd gener-
ation cephalosporins (including beta lactamase inhibitors)
constituted 21% of all antibiotics used. First generation
cephalosporins were most frequently used with a rate
of 20.8%. Fluoroquinolones and penicillins (including
beta lactamase inhibitors) were the groups prefered
after cephalosporins. In the departments for internal
diseases most frequently preferd antibiotics were 2nd
generation cephalosporins and fluoroquinolones, in the
surgical departments 1st generation cephalosporins, and
in the intensive care units 3rd generation cephalosporins
(including beta lactamase inhibitors) and carbapenems
(Table 3).
Total days of use was calculated to be 55.1 DDD/100
bed-days, 56.4 in the departments of internal diseases,Table 1 Antibiotic use variables in medical units
Number of patients Antibio
rat
Internal med. units 181 4
(Acute exacerbation of COPD) (49) (8
Surgical units 113 5
(Surgical prophylaxis) (101) (4
Intensive care units 14 7
Total 308 449.1 in the surgical departments, while in the intensive
care units was found to be 87.8 DDD/100 bed-days
(Table 4).
The study was carried out on 19 July 2011, the total
amount of all antibiotics were used in-hospital and the
total cost of antibiotics used was calculated according to
the price list of the General Directorate of Pharmaceuti-
cals of the Republic of Turkey on the same day. On the
day of the research the daily cost of the antibiotics used
in our hospital was 4104.79 TL (=2476.80 USD). The
cost per infected patient was 27.92 TL (=16.89 USD). In
the intensive care unit daily antibiotic costs were 546.08
TL (=329 USD), per infected paient daily costs were
49.64 TL (=29.95 USD). In the departments of internal
diseases daily antibiotic costs were 2793.08 TL (1685
USD), per infected patient being 36.27 TL (=21.89 USD).
Among the departments of internal diseases, the depart-
ment for chest diseases had the most frequent antibiotic
use and te highest number of in-bed patients. The daily
antibiotic costs of the department for chest diseases
was 1126.45 TL (679.69 USD), of which 20.48 TL
(=12.36 USD) per patient/day. Total antibiotic costs per
day in the surgical departments were found to be
765.63 TL (= 463.98 USD), of which per infected pa-
tient 12.98 TL (=7.86 USD)(Table 4).Discussion
The use of antimicrobial agent does not only diverse
between countries, but also diverse between the hospitals
of a same country. These differencies can be correlated with
hospital and patient features, antibiotic policies of the hos-
pitals, physicians preferences and with the differencies in
the educational and health systems [14].
Antimicrobial agents are the most frequently used drugs
in Turkey and they constitue 22% of all drugs used [2].
In our study, the rate of antibiotics used was found to
be 47.7%. In similar studies performed in our country
the in-hospital rate of antibiotic use ranges between
45.6% and 61%, coinciding with the rates we detected
[8,23,24]. In the Northern European countries the in-
hospital rates of antibiotic use are lower than in our












Table 2 Antibiotic usage rates of medical units
Internal medicine
units
The number of patients to which antibiotics
were administered/ number of patients
% Surgical units The number of patients to whom antibiotics
were administered/ number of patients
%
Internal medicine 3/42 7.1 General surgery 19/35 54.3
Neurology 1/21 4.8 Orthopedics 12/26 46.2
Cardiology 4/19 21.1 Neurosurgery 6/10 60
PTR 2/20 10 ENT 3/9 33.3
Dermatology 8/12 66.7 Plastic surgery 6/9 66.7
Infectious diseases 6/8 75 CVS 3/5 60
Pulmonary dis. 53/59 89.8 Chest surgery 7/10 70
Total 77/181 42.5 Urology 3/9 33.3
Intensive care unit 11/14 78.6 Total 59/113 52.2
PTR Physical Medicine and Rehabilitation, CVS Cardiovasculer Surgery, ENT Ear, Nose, and Throat/Head and Neck Surgery.
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found to be 61.9%. While in the departments for internal
diseases this rate was 76.6%, in the surgical departments
and in the intensive care units the rates were 38.9% and
81.8% respectively. While 32% of the patients received
antibiotics for surgical prophylaxis, the use of antibiotics
for acute exacerbation of COPD (29.9%) and penumonia
(14.3%) draws our attention. High rate of antibiotic use
is acceptable because one of the major pharmacologic
treatment used in acute exacerbation of chronic obstruct-
ive pulmonary disease(COPD) are antibiotics [27].
When we evaluated the duration of surgical prophy-
laxis as a whole, the proper antibiotic choice, adminis-
tration time and way were found to be only 27.7%
appropriate. The major reason of the low proper anti-
biotic use rate in the surgical departments compared to
other departments were the errors in the use of surgical
prophylaxis. While the antibiotic for surgical prophylaxis
was largely properly chosen, what was improper was
the duration of prophylaxis. The mean duration of surgi-
cal prophylaxis was found to be 4.74 days. In surgical





Penicillins J01CR 16.9 9.3
First generation cephalosporins J01DB 3.3 1.8
Second generation cephalosporins J01DC 23 12.7
Third generation cephalosporins J01DD 19.8 10.9
Carbapenems J01DH 2.1 1.2
Aminoglycosides J01GB 0.8 0.4
Imidazoles J01XD 0 0
Glycopeptides J01XA 3 1.7
Fluoroquinolones J01MA 22.9 12.7
Others 10.3 5.7
Total 102.1 56.4prophylaxis has been observed to be more inappropriate.
Surgical prophylaxis was most frequently used in the
orthopedics service. Average duration of surgical prophy-
laxis was 9.5 days and all of the patients were using more
than one drug combination containing antibiotics. Ur-
ology and ENT were services that implement the most
appropriate surgical prophylaxis. In similar studies, no
errors were seen in the agent used in the prophylaxis,
while the unnecessary extension of therapy was the
main problem [28,29]. The proper antibiotic use in the
intensive care units compared to the internal diseases and
surgical departments was the use of antibiotic according
to ‘evidence based’ (45.5%), and more regularly obtained
consultations from the department for infectious diseases.
The antibiotic use according to ‘evidence based’ in our
hospital consist only 5.4% of the total antibiotic use
and it is similar to other studies performed in our
country [30,31]. In order to improve the improper use
of antibiotics, eductional activities should be performed
periodically, policies of current antibiotic use should be
formed by the infection committees of the hospitals
and the clinical practices should be controlled.Surgical units Intensive care units Total Total rate
DDDs ACI DDDs ACI DDDs ACI %
0 0 0 0 16.9 5.5 10
30.7 27.2 1.3 9.3 35.3 11.5 20.8
3 2.7 0 0 26 8.4 15.2
10 8.8 6 42.9 35.8 11.6 21
1 0.9 2 14.3 5.1 1.7 3.1
6.7 5.9 0 0 7.5 2.4 4.4
3 2.7 0 0 3 0.9 1.7
0 0 1 7.1 4 1.3 2.4
1 0.9 1 7.1 24.9 8.1 14.7
0 0 1 7.1 11.3 3.7 6.7
55.4 49.1 12.3 87.8 169.8 55.1 100











Surgical units 12.98 7.86 49.1
(Surgical prophylaxis) 5.88 3.55 41.4
Intensive care units 49.64 29.95 87.8
Total 27.92 16.89 55.1
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of the antimicrobials used in our hospital. Cephalospo-
rins are followed by fluoroquinolones with 14.7% and
penicillins with 10% of use. Of the cephalosporins used,
21% were 3rd generation, 20.8% 1st generation and
15.2% 2nd generation, which ranks on the first 3 places
of the total drugs used. According to the ARPAC (Anti-
biotic Resistance, Prevention and Control) project, all
hospitals most frequently used penicillins, followed by
non-penicillin beta lactams and fluoroquinolones [32].
Antibiotic utilization rate in Turkey was found to be
higher compared to the European countries. Especially
the use of cephalosporins, penicillins and fluoroquinolones
is much higher than in the European countries [33,34].
The frequent use of cephalosporins and fluoroquinolones
lead to the emergence of resistant microorganisms, thus
problems such as the emergence of resistant pathogenes
in our area would be an inevitable consequence [35].
The ACI in our hospital was found to be 55.1 DDD/
100 bed-days. In the intensive care units the ACI was
87.8 DDD/100 bed-days, in the departments for internal
diseases 56.4 and in the surgical departments 49.1 DDD/
100 bed-days. Eventhough the proper antibiotic use in
the surgical departments was found to be lower than the
department for internal diseases and intensive care units,
the ACI value was lower. According to Akalın et al.’s
study [23] in a university hospital, the ACI in 2009 was
found to be 64.5 DDD/100 bed-days while in 2010 70.5
DDD/100 bed-days. These values are higher than the
values in our study. This fact can be linked to the fact
that in tertiary hospitals clinically more complicated and
seriously ill patients are being treated compared to
secondary hospitals. In a study by Vaccheri et al. [36]
conducted in an university hospital in Italy it was shown
that, the amount of antibiotics used, rised from 64.9
DDD/100 bed-day in 2002 to 76.7 DDD/100 bed-days in
2004. In the ARPAC Project conducted in 130 European
hospitals, the antibiotic use was found to be 792 + 147
DDD/1000 bed-days. According to this large scale study,
the antibiotic use in our country is parallel with southernand western Europe but higher than northern, middle and
eastern European countries [32].
If we keep in mind that antibiotics are the most fre-
quently used drugs in the hospitals, than we would know
that they constitute an important part of the total drug
expenditure. In our hospital the defined cost per infected
patient per day was 16.85 USD. As expected, the anti-
biotic use in the intensive care units for infected patients
was higher than in other clinics. Antibiotic use in the
surgical departments was found to be 7.86 USD per
infected patient per day, which is lower than other
departments. Despite of the unnecessary extension of
surgical prophylaxis, the reason of this is the choice of
less expensive 1st generation cephalosporins. However,
as the improper use of antibiotics is still high, the in-
hospital antibiotic expenditure can be reduced even
more. Reducing improper use of antibiotics would pre-
vent the incidence of life-threatening serious infections,
also preventing long hospital stays and higher health
expenditures. The department for pulmonary diseases
draws attention with the highest number of patients
and also with the highest number of patients using
antibiotics. The department for pulmonary diseases
uses 27.5% of the daily antibiotic costs. Vast majority of
the patients are hospitalized in this department due to
diseases caused by smoking. Smoking can be considered
as one of the factors that increases the use of antibiotics
in hospitals.
Our study, carried out with point-prevalence method
has certain limitations such as being single-centered, not
having resistance ratios calculated and involving only
one day of the year. The study was carried out in the
summer period. Especially pneumonia and acute exacer-
bation of COPD are diseases seen more oftenly in the
winter, and clinically more complicated diseases are less
encountered in the summer period. However, by apply-
ing a method inexpensive and easy to implement as the
point-prevalence, we can say that we gained detailed
knowledge of the antimicrobial use in our hospital.
As a result, the use of ATC/DDD system in hospitals
would provide internationally valid data in the evalu-
ation of antimicrobial use. We believe that, more effi-
cient utilization of infectious diseases experts in the use
of antibiotics in hospitals, creating of guides for anti-
biotic use specific to every hospital and more efficient
use of the microbiological laboratories may be of benefit
in the resolving of existing problems.
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